Directorate Change

26 February 2007 BOARD CHANGE DAVID TYLER APPOINTED NON-EXECUTIVE DIRECTOR Reckitt Benckiser plc (RB.L) today announced the appointment of David Tyler as an independent non-executive director. David Tyler (54) was Group Finance Director of GUS plc from February 1997 until October 2006. In addition to his financial role at GUS plc, he was responsible for the development of group strategy. Prior to joining GUS plc, he was Group Finance Director of Christie's International plc and in his early career he held positions within County NatWest Ltd and Unilever plc. He is a Fellow of the Chartered Institute of Management Accountants and a Member of the Association of Corporate Treasurers. He is currently a non-executive director of Burberry Group and Experian Group. Adrian Bellamy, Chairman of Reckitt Benckiser plc, commented "The Board is delighted that David has agreed to join us. He will bring a wealth of financial and business experience to the Board. I am sure he will make a significant contribution to the future success of the Company." For Further Information Tom Corran, SVP Investor Relations & Corporate Communications Telephone +44 (0) 1753 217 800 Liz Richardson , Company Secretary Telephone +44 (0) 1753 217 800 Fiona Fong, Head of Corporate Communications Telephone + 44 (0) 1753 217 800 Notes for Editors Reckitt Benckiser is the world leader in household cleaning, excluding laundry, and has a major presence in health and personal care. The Company has operations in 60 countries, sales in 180 and employs 22,000 people around the world. Amongst the Company's leading brands are Lysol, the world leader in disinfecting cleaning, Calgonit, Finish and Electrasol, the world leaders in automatic dishwashing, Woolite, world leader in garment care, Vanish & Spray 'n Wash, world leaders in fabric treatment; and Airwick and Mortein, number two brands in air care and pest control. In health and personal care leading brands include: Veet, the world number one depilatory, Dettol the world's leading antiseptic, Strepsils, the world number one sore throat tablet, Nurofen, the number two analgesic worldwide, and Clearasil, the world's leading anti-acne treatment. Reckitt Benckiser is headquartered in Slough just outside London and is listed on the London stock exchange. With a market capitalization of c.£18bn it ranks among the top 30 UK listed companies.. Reckitt Benckiser had net revenues of £ 4.9bn, operating profit of £1,059m, and net income of £786m in 2006.
UK 100